BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20851072)

  • 21. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
    Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
    Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mantle cell lymphoma activation enhances bortezomib sensitivity.
    Brennan SK; Meade B; Wang Q; Merchant AA; Kowalski J; Matsui W
    Blood; 2010 Nov; 116(20):4185-91. PubMed ID: 20570863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
    Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
    J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.
    Wang M; Han XH; Zhang L; Yang J; Qian JF; Shi YK; Kwak LW; Romaguera J; Yi Q
    Leukemia; 2008 Jan; 22(1):179-85. PubMed ID: 17898787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination.
    Vega F; Davuluri Y; Cho-Vega JH; Singh RR; Ma S; Wang RY; Multani AS; Drakos E; Pham LV; Lee YC; Shen L; Ambrus J; Medeiros LJ; Ford RJ
    J Cell Mol Med; 2010 Jun; 14(6B):1532-45. PubMed ID: 19656242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases.
    Yatabe Y; Suzuki R; Matsuno Y; Tobinai K; Ichinohazama R; Tamaru J; Mizoguchi Y; Hashimoto Y; Yamaguchi M; Kojima M; Uike N; Okamoto M; Isoda K; Ichimura K; Morishima Y; Seto M; Suchi T; Nakamura S
    Pathol Int; 2001 Oct; 51(10):747-61. PubMed ID: 11881727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mantle cell lymphoma: biological insights and treatment advances.
    Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.
    Sun B; Shah B; Fiskus W; Qi J; Rajapakshe K; Coarfa C; Li L; Devaraj SG; Sharma S; Zhang L; Wang ML; Saenz DT; Krieger S; Bradner JE; Bhalla KN
    Blood; 2015 Sep; 126(13):1565-74. PubMed ID: 26254443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantle cell lymphoma proliferates upon IL-10 in the CD40 system.
    Visser HP; Tewis M; Willemze R; Kluin-Nelemans JC
    Leukemia; 2000 Aug; 14(8):1483-9. PubMed ID: 10942246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma.
    Tang J; Zhang L; Zhou T; Sun Z; Kong L; Jing L; Xing H; Wu H; Liu Y; Zhou S; Li J; Chen M; Xu F; Tang J; Ma T; Hu M; Liu D; Guo J; Zhu X; Chen Y; Ye T; Wang J; Li X; Xing HR
    Genes Dis; 2019 Dec; 6(4):407-418. PubMed ID: 31832521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered apoptosis pathways in mantle cell lymphoma.
    Rummel MJ; de Vos S; Hoelzer D; Koeffler HP; Hofmann WK
    Leuk Lymphoma; 2004 Jan; 45(1):49-54. PubMed ID: 15061196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
    Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
    Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
    Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
    Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.
    Nabrinsky E; Danilov AV; Koller PB
    Curr Hematol Malig Rep; 2021 Feb; 16(1):8-18. PubMed ID: 33507515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
    Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
    Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of CD19 and CD43 in a patient with therapy-related acute myeloid leukemia and a history of mantle cell lymphoma.
    Hsieh YC; Lin CL; Tsao CJ; Hsieh PP; Tzeng CC; Chuang SS
    Kaohsiung J Med Sci; 2009 Jul; 25(7):389-94. PubMed ID: 19605331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.
    Khoury JD; Medeiros LJ; Rassidakis GZ; McDonnell TJ; Abruzzo LV; Lai R
    J Pathol; 2003 Jan; 199(1):90-7. PubMed ID: 12474231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.